showed direct interaction of High molecular Group Box-1 (HMBG1), a well-known DAMP with Toll-like receptor-4 (TLR-4) on DCs that affect their antigenic presentation in breast cancer patients (24). Here, TLR4 is linked to breast carcinoma.